Sugi Predict

Sugi Predict / Compounds / SCHEMBL4233644

SCHEMBL4233644

SCHEMBL4233644

CCS(=O)(=O)N1C[C@@H](C)N(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)[C@@H](C)C1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPK10 P53779 8/20 0.40
▸ MAPK8 P45983 7/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ DDX3X O00571 1/20 0.37
▸ MAPK9 P45984 1/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PIK3R1 P27986 2/20 0.35
▸ MTOR P42345 2/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ PABPC1 P11940 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ ROCK2 O75116 1/20 0.34
▸ LIMK1 P53667 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4244038 0.91 CYP1A2 (0.40) MAPK10MAPK8NPSR1HTTDDX3X
SCHEMBL4237716 0.89 MAPK10 (0.39) MAPK10MAPK8NPSR1HTTDDX3X
SCHEMBL4237715 0.89 MAPK10 (0.39) MAPK10MAPK8NPSR1HTTDDX3X
SCHEMBL400361 0.89 CACNA1G (0.44) HTTRAB9ANPC1MEN1KMT2A
SCHEMBL23573782 0.88 NPSR1 (0.42) MAPK10MAPK8NPSR1HTTDDX3X
SCHEMBL3204580 0.88 NPSR1 (0.41) MAPK10MAPK8NPSR1HTTDDX3X
SCHEMBL2254860 0.87 SMARCA2 (0.39) MAPK10MAPK8HTTMAPK9RAB9A
SCHEMBL29714051 0.87 MAPK10 (0.41) MAPK10MAPK8NPSR1HTTDDX3X
SCHEMBL402989 0.86 MAPK10 (0.40) MAPK10MAPK8NPSR1HTTDDX3X
SCHEMBL31555161 0.86 MAPK10 (0.40) MAPK10MAPK8NPSR1HTTDDX3X

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1959947-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS Cytokinetics, Inc. (US) 2008-08-27 — — EP claimed
US-20070197505-A1 Certain chemical entities, compositions and methods CYTOKINETICS, INC. 2007-08-23 — — US claimed
WO-2007075377-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INC. (US) 2007-07-05 — — WO claimed
US-20090247544-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2009-10-01 — — US disclosed
EP-1959947-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS Cytokinetics, Inc. (US) 2008-08-27 — — EP disclosed
US-20070197505-A1 Certain chemical entities, compositions and methods CYTOKINETICS, INC. 2007-08-23 — — US disclosed
WO-2007075377-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INC. (US) 2007-07-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197505-A1 Certain chemical entities, compositions and methods TNNC1, TNNI3, TNNT2 MAPK10 2706/4885MAPK8 3594/4885NPSR1 3300/4885
US-20090247544-A1 Certain Chemical Entities, Compositions and Methods TNNC1, TNNI3, TNNT2 MAPK10 2706/4885MAPK8 3594/4885NPSR1 3300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.